Putnam BioRevolution ETF (SYNB)

Assets	$4.76M
Expense Ratio	0.71%
PE Ratio	29.48
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.78%
Ex-Dividend Date	Dec 5, 2024
Payout Ratio	22.81%
1-Year Return	-6.89%

Volume	2
Open	27.22
Previous Close	27.45
Day's Range	27.21 - 27.55
52-Week Low	24.57
52-Week High	33.23
Beta	1.00
Holdings	38
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

49.86% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	8.39%
AbbVie Inc.	ABBV	5.73%
Corteva, Inc.	CTVA	5.56%
Bio-Rad Laboratories, Inc.	BIO	5.06%
Novonesis A/S	NVZMY	4.94%
AstraZeneca PLC	AZN	4.42%
Eli Lilly and Company	LLY	4.20%
Ascendis Pharma A/S	ASND	4.03%
Alphabet Inc.	GOOGL	3.79%
NVIDIA Corporation	NVDA	3.74%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.2139	Dec 9, 2024
Dec 6, 2023	$0.0211	Dec 11, 2023